SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Compare
1Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents Rank
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 15192
 
 
 
C07K PEPTIDES 979
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9129
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8120
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 471
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 386
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 389
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2105
 
 
 
C07D HETEROCYCLIC COMPOUNDS 2122
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 274

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0005,181 SMALL MOLECULE ANTAGONISTS OF THE APELIN RECEPTOR FOR THE TREATMENT OF DISEASEJun 20, 13Jan 02, 14[C07D]
2013/0343,989 Methods and Compositions Related to Internalizing RGD PeptidesJan 30, 13Dec 26, 13[A61K, C07K]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USESep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONFeb 08, 13Aug 15, 13[G06F]
2013/0196,896 CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERSFeb 28, 11Aug 01, 13[A61K, C07K]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEDec 10, 12Jul 18, 13[A61K]
2013/0164,306 COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERSNov 15, 12Jun 27, 13[C07K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISDec 02, 10Jun 20, 13[G01N]
2013/0157,947 COMPOUNDS FOR STEM CELL DIFFERENTIATIONMar 23, 12Jun 20, 13[C12N, C07D, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,686,003 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcificationDec 07, 11Apr 01, 14[A61K]
8,642,283 Screening assay for agents that alter target of rapamycin activityMay 26, 06Feb 04, 14[C12Q, G01N]
8,637,635 Peptides that selectively home to heart vasculature and related conjugates and methodsJan 29, 09Jan 28, 14[A61K, C07K]
8,598,316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignanciesMar 26, 10Dec 03, 13[A61K]
8,536,132 Lymphatic zip codes in tumors and pre-malignant lesionsFeb 10, 11Sep 17, 13[A61P, A61K]
8,506,965 R-RAS activity in vascular regulationNov 11, 05Aug 13, 13[A61K]
8,487,131 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)Dec 03, 10Jul 16, 13[C07C, A61K]
8,470,780 Methods and compositions related to targeting wounds, regenerating tissue, and tumorsApr 19, 12Jun 25, 13[A61K, C07K]
8,466,311 Neuroprotective compositions and methodsSep 19, 11Jun 18, 13[C07C]
8,431,529 Bi-dentate compounds as kinase inhibitorsDec 16, 10Apr 30, 13[A01N, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0046,446 p16 MEDIATED REGULATION OF NMDA RECEPTORSAug 12, 11Feb 23, 12[C07H, C07K]
2012/0014,974 METHODS OF MODULATING CELL DEATH BASED ON THE BIT1/AES REGULATORY PATHWAYJun 06, 11Jan 19, 12[A61P, C12Q, A61K]
2011/0318,362 NOVEL CARD PROTEINS INVOLVED IN CELL DEATH REGULATIONAug 08, 11Dec 29, 11[C12N, A61P, G01N, A61K, C07K]
2011/0301,095 METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASISJun 06, 11Dec 08, 11[C40B, A61P, C12Q, G01N, A61K]
2011/0293,556 TREATMENT OF INSULIN RESISTANCE/METABOLIC SYNDROME TO ALLEVIATE THE RISKS OF DEMENTIAAug 08, 11Dec 01, 11[A61B, A61P, A61K]
2011/0288,002 NOVEL BAG PROTEINS AND NUCLEIC ACID MOLECULES ENCODING THEMJul 11, 11Nov 24, 11[C07H, A61K, C07K]
2011/0230,364 METHODS FOR IDENTIFYING MODULATORS OF APOPTOSISMar 21, 11Sep 22, 11[C40B]
2011/0201,780 NOVEL DEATH DOMAIN PROTEINSMar 17, 11Aug 18, 11[C07K]
2011/0189,711 PAAD DOMAIN-CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USENov 09, 10Aug 04, 11[C12N, C07H, C12P, C12Q, G01N, C07K]
2011/0071,213 CARD-DOMAIN CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USENov 01, 10Mar 24, 11[C12N, C07H, C12P, G01N, A61K, C07K]
2011/0067,126 GAB1 INVOLVEMENT IN GLUCOSE HOMEOSTASIS REGULATION BY HEPATOCYTESSep 10, 10Mar 17, 11[A01K, C12Q]
2011/0008,319 CARD DOMAIN CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USENov 30, 09Jan 13, 11[C12N, C07H, A61P, A61K, C07K]
2010/0324,267 NOVEL TRAF FAMILY PROTEINSDec 18, 09Dec 23, 10[C07H, C07K]
2010/0279,300 METHODS FOR DETERMINING THE PROGNOSIS FOR PATIENTS WITH A PROSTATE NEOPLASTIC CONDITIONApr 09, 10Nov 04, 10[C12Q, G01N]
2010/0168,162 SELECTIVE INHIBITORS OF AKT AND METHODS OF USING SAMEDec 22, 09Jul 01, 10[C07D, A61P, A61K]
2010/0160,607 p16 MEDIATED REGULATION OF NMDA RECEPTORSJun 09, 09Jun 24, 10[C07H, C07K]
2010/0093,623 COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOFJul 16, 09Apr 15, 10[C12N, A61P, G01N, A61K, C07K]
2010/0076,175 MOLECULES THAT SELECTIVELY HOME TO VASCULATURE OF PREMALIGNANT OR MALIGNANT LESIONS OF THE PANCREAS AND OTHER ORGANSSep 14, 09Mar 25, 10[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!